Abridge builds AI software that listens to conversations between clinicians and patients and drafts the clinical notes doctors would otherwise type, mainly for large health systems. In 2024, Kaiser Permanente rolled it out across its hospitals and medical offices in what was then the largest generative AI deployment in health care. With the patient's consent, clinicians record the visit, and a structured note is ready in their electronic health record when it ends, with each part traceable to the transcript and audio. It also captures orders, billing codes, and patient summaries, and health systems pay for it through enterprise subscriptions. Abridge was founded in Pittsburgh in 2018 and is based in San Francisco.
Work here?Claim your company
Industries
Company Size
201-500
Company Stage
Series E
Total Funding
$757.5M
Headquarters
Pittsburgh, Pennsylvania
Founded
2018
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$757.5M
Above
Industry Average
Funded Over
6 Rounds
Industry standards
Meet the AI Assistant for healthcare. The next era of clinical software won't be clicked through. It'll be talked to. Abridge led the shift to ambient AI in clinical documentation, centering the patient conversation and cutting the after-hours charting clinicians used to take home. Yet, the rest of the day is still spent on tabs, clicks, and navigating fields. Clinicians should be able to do what everyone else can now do with consumer chatbots and agents: say what they need and get it. That's why Abridge built Abridge Assistant, the AI assistant for healthcare. Assistant is built from the same AI research and clinician-led evaluation that brought Abridge's ambient notes to more than 300 enterprise health systems. Clinicians can ask questions and delegate tasks to Assistant in their own words. As of its September release, every clinician at every Abridge health system has access to Assistant, whether or not they use Abridge for documentation. Ask Assistant about a patient, and it pulls together the relevant details from across that patient's chart, with each source cited. Clinical questions come back with current guidelines, and calculators open with chart values already filled in. Assistant also personalizes the note and drafts artifacts such as referrals and handoffs for the clinician to review. All of it runs inside the security and governance review framework of the health system. Below, Matt Troup, a PA-C and Abridge Clinical Strategy Principal, explains what clinicians need from an AI assistant. Janie Lee, Abridge VP of Product, explains what it took to build it. What clinicians need from their AI assistant: Matt Troup. In hospital medicine, questions often come at inopportune times: walking out of a room, halfway through a note, overnight when a lab comes back. The tasks pile up right behind them, and each one means more time clicking through the chart before the shift ends. Most of the standalone tools I've used share the same problem, regardless of how much they tout AI. They know a lot of medicine, but they don't know my patient. A response is only as specific as the data preceding it, so I end up doing the prompting myself: retyping comorbidities, current meds, and what Abridge tried last admission, then filtering out whatever doesn't apply. These tools rarely show how they got to a response, leaving me uncertain how they generate information or where it's pulled from. The chart has the opposite problem. It holds every detail collected about the patient, sometimes years of notes, results, and outside records, but I have to piece the story together myself, and it's easy to miss something. Add the documentation that follows, and a lot of my time is wasted hunting for information and clicking through screens to act on it, and there's no guarantee that I will find everything I need in the time I have. Health systems have their own requirements. Some of the tools clinicians reach for have not been reviewed and integrated by their organizations, which creates its own set of problems. And institutional knowledge, like clinical pathways, often lives in a policy library that too few people consult. When Abridge started building Assistant, this was my wish list: * It knows the patient: Responses should reflect the chart and the conversation, not just general knowledge. * It's where the work happens: No new tab, no copy and paste, no starting over. * I stay in charge: It does the digging and the first draft but signing off is up to me. * It shows the work: It cites which parts of the chart it pulled and which sources it checked, so I can follow the reasoning before I act on it. * My health system stands behind it: It has to clear security and governance review and be fully integrated into the technology I'm already using. How Abridge built Abridge Assistant: janie Lee. Abridge built Assistant for the clinicians at Abridge like Matt and clinicians who work at every one of its partner health systems - for those who are stuck between two eras of software. They deserve better than a broken workflow of legacy software built around a thousand clicks, with newer AI tools that fall short layered on top. Assistant is built to close both gaps, working from the patient's chart and arriving via a simple chat or voice interface, backed by robust and evaluated intelligence. Input from clinicians and health systems shaped its key development decisions: * Start with the context. Assistant draws on the chart, the conversation, and the evidence clinicians already trust, so each response is shaped to the patient in front of them. Context includes a health system's own clinical pathways, so responses further reflect how care is delivered in that organization. * Keep it simple, wherever clinicians work. The Assistant interface is consistent inside the EHR and on the clinician's phone, and it stays simple as capabilities grow. The clinician orchestrates, and Assistant carries the context from one step to the next. Ask what changed since a patient's last admission, for example, and the response can become a draft handoff in the same thread. * Show the work. A request like "compare treatments for this patient" sets off a chain of work behind the scenes, from pulling the right context to checking that the response is complete. Assistant shows those steps as they happen, so the clinician can see the reasoning and which sources are referenced as a response is compiled. * Evaluate continuously. Abridge evaluate Assistant with human and LLM judges, using clinician-built rubrics for clinical quality and safety, before and after a capability ships. Testing also includes a fresh review of existing PHI protections, so patient data stays under the same controls across Abridge. Assistant's simplicity hides most of the effort behind it. A lot of this work was in progress before Assistant existed: Abridge was already connected to multiple EHRs and embedded in the clinical workflow, with security, compliance, and AI governance built in from day one. Few products start with that foundation, and Assistant was built on it. Because clinicians can open Assistant inside Abridge, under approvals their health systems have already granted, it's been adopted at scale already. How clinicians use Assistant in practice: Matt Troup. Take a typical morning in the hospital. Before rounds, Assistant shows me what has changed for each patient on my list, so I'm not starting from scratch. For a patient I'm meeting for the first time, using only my voice, I ask what happened at their last admission. The first response from Assistant surfaces key details, which means my follow-up question is more precise. I might ask how the patient's kidney function affects an antibiotic choice. The response brings the evidence together with this patient's history, with guidelines cited and the health system's own pathway included. Assistant can then open a calculator with chart values already filled in for me to check. When care moves to another team, I can ask Assistant to turn what Abridge has just worked through into a draft handoff, then review and edit it. That's what Abridge mean by orchestrating the workflow instead of clicking through it. I decide what I need from the past, combine it with what's happening now, and choose the next action. Assistant does the searching and the first draft. I make the clinical judgments. Unlike the standalone apps I described before, I can follow the clinical question through to the work it creates, rather than rebuilding the context each time I move from sorting out what matters from the chart, to considering a decision, and, finally, to communicating a plan. The setting may change - a hospital ward, a clinic, an emergency department - but the need is familiar. Abridge need to understand the patient, decide what comes next, and make sure the plan reaches the people who depend on it. Better-informed decisions flow into the documentation and into how Abridge talk with the patient. This is why the ambition has to be bigger than fewer clicks. Abridge is building toward a more connected way of working, where the effort that goes into understanding a patient carries forward into the decisions, documentation, and conversations that follow. The best clinicians I've worked with weren't simply the ones who knew the most facts. They were the ones who knew how to apply what they knew to the person in front of them. Abridge Assistant is designed to support that work: less effort piecing the story together, more attention to the person living it. Where Abridge is taking assistant and what this means for the future of care: janie Lee. Near term, Abridge is focused on taking on more of the clinical and clerical work clinicians have asked Abridge to offload. Abridge partner closely with clinicians at its 300+ health systems and are always working with them on improving Assistant's capabilities. Longer term, Abridge want Assistant to stay with clinicians across devices, and to work across systems. A clinician's work can span multiple EHRs and the systems that payers and life sciences organizations manage. Assistant will help clinicians across those boundaries. Its goal is for clinicians to spend less time on tasks and more on what they're trying to accomplish for the patient. Getting a patient the right outcome, whether that's a medication or a spot in a clinical trial, takes front office and back office work from clinicians, nurses, payers, and life sciences. Assistant is how Abridge plan to move that coordination into the background, while the experience stays simple for clinicians.
Now in Practice: September 2026. Welcome back to Now in Practice. One throughline in this month's release is the timing and detail behind how complex care makes it into the record. Diagnoses organized and refined while the clinician is still in the note. Related conditions grouped together so combination codes can surface before the chart closes. Cues that capture what was discussed during an inpatient stay while the story is still fresh. So much of what often comes back weeks later as a retrospective query was known in the moment, and each of these updates is a version of the same goal: settling that detail at the point of care so the record reflects the full complexity of the care delivered and holds up on review. Alongside them, two updates give administrators more direct control over their Abridge implementation, and two specialty model enhancements now capture the details that define allergy and palliative care. Closing CDI gaps before the chart reaches coding. Three capabilities in this release are focused on closing the gap between the care delivered and the care that is documented: the diagnosis that's accurate but not specific enough, the combination code split across a flat list, and the observation made at the bedside that never reaches the note. This builds on Abridge's Query Engine, introduced in July, which surfaces AAPC-compliant CDI queries inline in the note when a documentation gap is present. This month extends the same idea to the diagnosis list itself and to the smaller details of an inpatient stay, where a formal query would be heavier than the detail warrants. Visit Dx integration enhancements. Its Visit Dx integration now brings problem headers, diagnosis search, and specificity options together in a single place, within the documentation workflow. Diagnoses can be organized under the right headers, found or replaced inline, and refined to a more specific option when the modifier detail is available, all without stepping out of the note. The goal is an accurate diagnosis list that's settled during documentation, rather than days or weeks later when a review or query flags what's missing. Problem grouping. Abridge now groups related diagnoses on the problem list into logical clusters, organized the way clinicians reason about a patient rather than as a flat list. With related conditions side by side, combination codes are easier to spot for review while the clinician is still in the note. A combination code split across a flat list is exactly the kind of gap retrospective review exists to reconstruct; catching it at the source means the case mix reflects the complexity of the patients actually treated. Query Engine: inpatient cues. While clinicians chart an inpatient stay, Abridge now surfaces non-blocking cues that point to care already discussed or assessed: whether wounds were present when skin integrity was checked on admission, or the key decisions from a goals-of-care conversation. Each cue carries its supporting evidence and can be acted on or dismissed in one step. Because the prompt arrives while the context is still fresh, the full complexity of the care makes it into the chart, and clinicians can have more confidence that nothing was left out. Cued, not interrupted. The instinct with any documentation prompt is to make it impossible to ignore. But a prompt that blocks signature teaches clinicians to click through it, and once that habit forms, the prompts that matter get the same treatment as the ones that don't. Cues are dismissible because the clinician is the one who knows whether a detail belongs in the record, which is also what makes every acted-on cue meaningful. More control for the teams running Abridge. As implementations scale across care settings, it becomes more important than ever for the teams administering Abridge to be able to manage access on their own timeline and verify the work the platform does on their behalf. Two updates this month give project and CDI teams more direct control over their Abridge implementation. Self-Serve user management. Partners can now add, edit, and remove user access directly from the Enterprise Portal, with users across surfaces visible in one place. For Abridge Inside, an optional approval queue routes clinician access requests to admins to approve or deny, replacing manual updates to the Epic Ambient Allowlist for organizations looking to centralize Abridge access. Every hire, role change, and departure can be handled as it happens. It's a direct response to partner feedback: the time between a staffing change and a clinician's working account shouldn't depend on someone else's queue. QA Viewer for Query Engine logs. CDI teams can now open any Query Engine query in the QA Viewer and see its full record alongside the clinical note: the documentation gap it surfaced, the evidence behind it, the compliance rationale, and how the clinician responded. Instead of re-checking every query by hand, reviewers can spot-check the engine's judgment case by case and build confidence in the routine layer of query work, so their time goes to the complex cases that need real judgment. Deeper detail for specialty care. Every specialty has terminology and details that a general note structure may not be tuned to surface. Two recent note enhancements capture what matters most in allergy/immunology and palliative care. Allergy/Immunology model enhancement. Allergy/Immunology notes now record allergens, triggers, and reaction timelines exactly as discussed, so a peanut allergy stays a peanut allergy. The HPI captures medications by name, dose, and device along with prior skin prick and IgE results, and the plan carries immunotherapy schedules and dosing. In allergy care, the specific allergen and the timing of a reaction are the clinical picture, and the note should carry them that way. Palliative model enhancement. The palliative note now generates a dedicated Goals of Care subsection in the HPI, with a corresponding summary of action steps in the Assessment & Plan. The note also improves capture of medication dosages and changes, including MEDD and pain pump settings, along with palliative-specific scores like the Palliative Performance Scale (PPS). Goals-of-care conversations are often the most consequential part of a palliative visit, and they deserve a place in the note that matches their weight. This month's release is about the record keeping pace with the care. A diagnosis is refined before the note is signed, a combination code surfaces while the clinician can still act on it, and what was observed at the bedside reaches the chart while the story is fresh. Behind the note, admins manage access on their own timeline and CDI teams can see exactly why each query was raised. That's what Abridge shipped in September, and Abridge'd love to have you see it in practice.
Abridge, Free Market Health reflect on growth at life sciences summit. Abridge and Free Market Health, both Pittsburgh-based, closed out Wednesday's Bio + Health Summit hosted by the Pittsburgh Life Sciences Alliance. Reba Schenk, Abridge's vice president of partner experience, and Joe Cardosi, CEO of Free Market Health, both spoke during a Bio + Health Summit panel titled "Growth Stage Lessons" that was moderated by Patrick Colletti, CEO of CoSage. Abridge, founded in 2018 in Pittsburgh, uses generative AI to transcribe doctor-patient conversations. Considered one of Pittsburgh's "Unicorns," it collaborates with over 300 U.S. health systems. Free Market Health, established in 2019, connects insurance providers with specialty drug pharmacies. It manages $15 billion in annual specialty medication spend and serves 11 million patients. Both companies have impressive portfolios, but Schenk and Cardosi noted that they've had some growing pains along the way, while also making significant gains in their fields. Schenk, who joined Abridge in 2024, explained that initially their company started as a patient-facing app. Eventually, Abridge learned that the clinicians they worked with did not like the idea of patients recording their visits. Abridge pivoted and since then has continued to improve its services. Schenk said that the day she realized the scale of Abridge's impact was when the company ran out of compute capacity for its services. "The early days were full of technical challenges like that, and also human challenges of taking these personal relationships that our CEO had built, that were tech friends of his, and scaling that authenticity because we're so passionate about human connection in healthcare," Schenk said. "Figuring out how to scale both the technology and the human side of it that quickly, when we had 10 major health systems at one point going live a week, is truly unprecedented for what I've seen in healthcare." In recent years, Abridge has expanded its footprint to San Francisco and New York, and initiated partnerships with other major companies like Nvidia and Eli Lilly. Over the years, Abridge has also seen significant growth in its staffing numbers. Schenk said that when she first started with the company, there were around 60 people within the company and now it has expanded to over 600. The mission to help people is something that really drives workers at Abridge, according to Schenk. But she noted that sometimes it becomes hard to translate that mission. "We wanted to build very thoughtful experiences for our customers, so we have to be intentional about that, and we have to encourage each other and set the standards," she said. "But I think it is also about taking the time for human connection internally. We had someone who was one of the first people who departed our team a couple of weeks ago, and I chatted with her before she left. And one of the things she told me that was hard to hear is that she felt disconnected. And it was a good reminder to me that it's not just about connecting with our customers; it's about connecting with each other and taking the time to remind each other why we're doing the work." Cardosi, when reflecting on Free Market Health's first days, said that it took them a while to "crack the code" of what they were doing. He said the impact became clear only when they began expanding into Pennsylvania and states like North Carolina. Cardosi said that they're working to expedite the specialty drug process for patients, acknowledging that they're sometimes forgotten about during the pharmaceutical process. "Let's get the medication to the patient as fast as humanly possible and make sure it's a high-quality pharmacy," he said. "We're building the things, whether that's features, capabilities, integrations, to get in that moment as often as possible, as early as possible, and to make that connection to a high-quality pharmacy happen as seamlessly, systematically as possible, so the patients don't have to be the advocates for their care." Free Market Health has partnered with other organizations like Highmark's specialty pharmacy, which has helped ease the process for patients. Cardosi emphasized that their overall goal is to help people and improve their experience in the healthcare system. "I think we want to make an actual impact. Maybe a logo or something on a building will be an indicator or signal that we're making an impact, but for us, that's already helping patients, people in their most vulnerable times," he said. "We have a super compelling opportunity to make an impact on people in really tough times in their lives by showing up as a technology company and helping the thing that's hard for them today be a little bit easier." Read the full story from from Pittsburgh Business Times.
AI model costs are pushing startups towards cheaper open weigh. Harvey's gross margin fell to minus 50% by June before it built a model of its own on a Chinese base, and Mistral's chief executive spent July warning European buyers that this is what renting a closed model does to you September 21, 2026 - 5:30 pm Harvey's gross margin fell from about 50% at the start of this year to minus 50% by June as customer usage of its AI agents spiked, and turned positive again only after it released a model of its own built on Moonshot's Kimi K3. Abridge, Decagon, Ramp and Rogo are making similar moves, and Sequoia Capital and General Catalyst are funding the shift. Harvey's gross margin fell from about 50% at the start of this year to minus 50% by June, Bloomberg reported, citing a person familiar with the matter. The legal startup is valued at $15.6B. Customer usage had spiked after a March update to its AI agents. The cost was the models it rented. Harvey has seen a twentyfold rise in token usage this year, according to the company. Both OpenAI and Anthropic now charge enterprises for model usage on top of base subscription fees. Its founders knew the spike would not survive contact with those rates. So it stopped renting. In August Harvey released its first in-house model, post-trained on Kimi K3 from the Chinese lab Moonshot. Gross margins turned positive again after that launch and other changes to how it uses AI, people familiar with the work told Bloomberg. Harvey declined to comment on specific financials. It is not alone. Abridge is building a clinical model on Nvidia's open weights, and Decagon now routes 80% of customer queries through models of its own. Ramp raised $750M in June and is weighing training for the first time. "It made absolutely no sense a year ago," co-chief executive Karim Atiyeh said. "It's starting to make a lot more sense now." Anthropic has noticed. At an investor forum in its offices it showed a slide on startups building their own models, with a reminder that Harvey still needs Opus for its hardest tasks. Mistral's Arthur Mensch spent July arguing that closed models give providers immense leverage, and named Anthropic cutting off Windsurf while building Claude Code. September made his case for him. OpenAI moved to end its Cursor contract after SpaceX bought the company, citing past terms of service breaches by Musk businesses. European buyers have switching rights under the Data Act, but those cover a customer leaving a supplier, not a supplier leaving a customer. Europe has its own Harvey. Legora, in Stockholm, reached $100M in revenue inside 18 months and now serves more than 1,200 firms, and it has never said whose models it runs on. Not everyone thinks the answer matters. "Having your own model or not is such the wrong question," said Menlo Ventures partner Matt Kraning. "In most cases, it tends to be a lot of cosplay."
Abridge announced a pre-bill review capability for clinical documentation integrity (CDI), coding, and revenue cycle teams. The feature reviews inpatient claims before submission, comparing final coded diagnoses and diagnosis-related groups (DRG) against clinical documentation. The platform identifies discrepancies and provides supporting evidence, allowing teams to resolve issues before claims become denials. Abridge does not alter documentation, codes, or claim status—CDI teams retain control over holding, correcting, or releasing claims. The capability builds on Abridge's existing clinician intelligence platform, which captures records during clinical interactions. By extending this platform into pre-bill review, Abridge enables comparison between clinical records and claim diagnoses before submission. This approach aims to ensure coded records accurately reflect the documented complexity of care, addressing the gap between care delivery and reimbursement.
Find jobs on Simplify and start your career today
Industries
Company Size
201-500
Company Stage
Series E
Total Funding
$757.5M
Headquarters
Pittsburgh, Pennsylvania
Founded
2018
Find jobs on Simplify and start your career today